Clinical Trial

A Pilot Study Of The ALPFA Benign Prostatic Hyperplasia (BPH) Pulsed Field Ablation (PFA) System

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The ALPFA Medical BPH Pilot Study is a prospective, open label, single arm pilot study to assess the use of the ALPFA BPH PFA System in the treatment of men over the age of 45 with obstructive urinary symptoms associated with BPH. Male subjects will be consented and undergo protocol-defined baseline assessments. Those who meet study entry criteria will be enrolled and treated with the ALPFA BPH PFA System and then undergo follow-up with protocol-defined assessment.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-03 -> 2030-03 2026-06-26
minor Completion pushed: 2027-03 -> 2030-03 2026-06-26
Trial Details
NCT Number NCT06965582
Lead Sponsor ALPFA Medical
Conditions Benign Prostatic Hyperplasia
Enrollment 100 participants
Start Date 2025-02-07
Primary Completion 2030-03 (estimated)
Study Completion 2030-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-25